Sec Form 4 Filing - O'Neill Kevin Michael @ GE HealthCare Technologies Inc. - 2023-01-03

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person O'Neill Kevin Michael 2. Issuer Name and Ticker or Trading Symbol GE HealthCare Technologies Inc. [ GEHC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO, PDx (Last) (First) (Middle) 500 W. MONROE STREET 3. Date of Earliest Transaction (MM/DD/YY) 01/03/2023 (Street) CHICAGO, IL60661 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common stock, par value $0.01 per share 01/03/2023 A 59( 1 ) A 59 I By share incentive plan trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (right to buy) $ 129.52 01/04/2023 A 1,653 ( 2 ) 09/13/2023 Common stock, par value $0.01 per share 1,653 ( 1 ) 1,653 D Employee Stock Option (right to buy) $ 142.15 01/04/2023 A 343 ( 2 ) 09/05/2024 Common stock, par value $0.01 per share 343 ( 1 ) 343 D Employee Stock Option (right to buy) $ 142.15 01/04/2023 A 3,329 ( 2 ) 09/05/2024 Common stock, par value $0.01 per share 3,329 ( 1 ) 3,329 D Employee Stock Option (right to buy) $ 135.92 01/04/2023 A 3,672 ( 2 ) 09/11/2025 Common stock, par value $0.01 per share 3,672 ( 1 ) 3,672 D Employee Stock Option (right to buy) $ 161.3 01/04/2023 A 5,051 ( 2 ) 09/30/2026 Common stock, par value $0.01 per share 5,051 ( 1 ) 5,051 D Employee Stock Option (right to buy) $ 99.21 01/04/2023 A 5,877 ( 2 ) 11/17/2027 Common stock, par value $0.01 per share 5,877 ( 1 ) 5,877 D Employee Stock Option (right to buy) $ 76.66 01/04/2023 A 4,592 ( 2 ) 03/19/2028 Common stock, par value $0.01 per share 4,592 ( 1 ) 4,592 D Employee Stock Option (right to buy) $ 40.4 01/04/2023 A 13,275 ( 2 ) 12/21/2028 Common stock, par value $0.01 per share 13,275 ( 1 ) 13,275 D Employee Stock Option (right to buy) $ 57.74 01/04/2023 A 3,106 ( 2 ) 03/19/2029 Common stock, par value $0.01 per share 3,106 ( 1 ) 3,106 D Employee Stock Option (right to buy) $ 51.67 01/04/2023 A 1,614 ( 2 ) 04/11/2029 Common stock, par value $0.01 per share 1,614 ( 1 ) 1,614 D Employee Stock Option (right to buy) $ 63.51 01/04/2023 A 10,820 ( 3 ) 03/02/2030 Common stock, par value $0.01 per share 10,820 ( 1 ) 10,820 D Restricted Stock Units ( 4 ) 01/04/2023 A 1,622 ( 5 ) ( 5 ) Common stock, par value $0.01 per share 1,622 ( 1 ) 1,622 D Restricted Stock Units ( 4 ) 01/04/2023 A 6,519 ( 6 ) ( 6 ) Common stock, par value $0.01 per share 6,519 ( 1 ) 6,519 D Restricted Stock Units ( 4 ) 01/04/2023 A 5,568 ( 7 ) ( 7 ) Common stock, par value $0.01 per share 5,568 ( 1 ) 5,568 D Restricted Stock Units ( 4 ) 01/04/2023 A 9,106 ( 8 ) ( 8 ) Common stock, par value $0.01 per share 9,106 ( 1 ) 9,106 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other O'Neill Kevin Michael 500 W. MONROE STREET CHICAGO, IL60661 CEO, PDx Signatures /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 01/05/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. ( 2 )Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. ( 3 )Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is fully exercisable immediately and 50% will become exercisable on March 2, 2023. ( 4 )Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. ( 5 )Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. ( 6 )Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. ( 7 )Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. ( 8 )Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.